Font

Aa Aa Aa

Background color

A A

Site version

Color Black and white
1930 1938 1954 1964 1975 1976 1988 1994 1998 2002 2004 2006 2007 2012 2015 2018 2019

History

1930

The Kyiv branch of the Ukrainian Institute of Experimental Endocrinology is established. In 1932, the branch releases its first drugs —Hematogen liquid and in tablets.

1938

New production facilities of the Kyiv branch are built. In 1940, the branch produced over 4 million units.

1954

Darnitsa Chemical and Pharmaceutical Plant is established. The company increases its production base.

1964

Glass-blowing and ampoule-tablet workshops are commissioned. Production of injectable solutions increases to 100 million ampoules per year.

1975

New buildings are constructed: chemical and tablet workshops, finished goods warehouse.

1976

Kyiv Industrial Chemical and Pharmaceutical Association Darnitsa is established, consisting of Darnitsa and Borshchahivskyi Chemical and Pharmaceutical Plant, the Kyiv Vitamin Plant, and Monastyryshchenskyi Chemical and Pharmaceutical Plant.

1988

Production facilities begin to be overhauled with imported equipment.

1994

Change of ownership to JSC Pharmaceutical firm Darnitsa. Volodymyr Zahorii is elected Director General.

1998

Darnitsa ranks No. 1 by circulation of medicines in kind. As of now, the company is still the undisputed leader.

2002

Start of production of sterile cephalosporin antibiotics in accordance with GMP requirements.

2002

Independent audit by British experts for compliance with GMP requirements. In 2003, the company receives the first national GMP certificate (production of sterile antibiotics for the preparation of injection solutions in vials).

2004

Darnitsa creates specialized production facilities for macrolide antibiotics and medicines in the form of drops.

2006

The new laboratory facility starts its work in accordance with international standards.

2007

The implemented logistics complex project with 100% process automation is the first and so far only warehouse of this level in the pharmaceutical industry in Ukraine and Eastern Europe.

2012

Full-scale technical reequipment of the ampoule shop floor. Annual production increases to 400 million ampoules.

2015

The first production of infusion solutions in Ukraine opens. Production investments amounts to EUR 20 million.

2018

Project for SAP system migration to Microsoft Azure cloud platform is implemented.

2019

The company has identified a new development vector - the establishment of an international pharmaceutical brand, complex generics field leadership, the development of fully digital company. At this time, Darnitsa has updated its logo - now it's a rethought microscope that is a symbol of continuous development and retrieval.

Specialized edition for medical institutions and doctors.

How Darnitsa Healed Sophia

Learn more